New fungal pathogens

Current Clinical Topics in Infectious Diseases

Volumn , Issue 17, 1997, Pages 205-235

  Bodey, Gerald P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

FUNGUS; HUMAN; IMMUNE DEFICIENCY; MYCOSIS; PATHOGENICITY; REVIEW;

ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; FUNGI; HUMANS; IMMUNOCOMPROMISED HOST; MYCOSES;

EID: 0030628872     PISSN: 01953842     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (134)

1. Schaffner A, Douglas H, Brande A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest 1982;69:617-631.
2. Fincher RME, Fisher JF, Lovell RD, et al. Infection due to the fungus Acremonium (Cephalosporium). Medicine (Baltimore) 1991;70:398-409.
3. Morrison VA, Haake RJ, Weisdorf DJ. The spectrum of non-Candida fungal infections following bone marrow transplantation. Medicine (Baltimore) 1993;72:78-89.
4. Bodey GP. Fungal infections complicating acute leukemia. J Chronic Dis 1966;19:667-687.
5. Walsh TJ, Newman KR, Moody M, et al. Trichosporonosis in patients with neoplastic disease. Medicine (Baltimore) 1986;65:268-322.
6. Sides EH III, Benson JD, Padhye AA. Phaeohyphomycotic brain abscess due to Ochroconis gallopavum in a patient with malignant lymphoma of a large cell type. J Med Vet Mycol 1991;29:317-322.
7. Blinkhorn RJ, Adelstein D, Spagnulo PJ. Emergence of a new opportunistic pathogen. J Clin Microbiol 1989;27:236-240.
8. Wingard JR, Merz WG, Rinaldi MG, et al. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991;325:1274-1277.
9. Goldman M, Pottage JC Jr, Weaver DC. Candida krusei fungemia. Report of 4 cases and review of the literature. Medicine (Baltimore) 1993;72:143-150.
10. Rippon JW. Medical mycology. The pathologic fungi and the pathogenic actinomycetes. 3rd ed. Philadephia: WB Saunders, 1988.
11. McGinnis MR. Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology. J Am Acad Dermatol 1983;8:1-16.
12. Friedman GC, Warren R, Hartwick J, et al. Allergic fungal sinusitis: report of three cases associated with dematiaceous fungi. Am J Clin Pathol 1991;96:368-372.
13. Washburn RG, Kennedy DW, Begley MG, et al. Chronic fungal sinusitis in apparently normal hosts. Medicine (Baltimore) 1988;67: 231-247.
14. Klein AS, Tortora GT, Malowitz R, Greene WH. Hansenula anomala: a new fungal pathogen: two case reports and a review of the literature. Arch Intern Med 1988;148:1210-1213.
15. Goss G, Grigg A, Rathbone P, Slavin M. Case report. Hansenula anomala infection after bone marrow transplantation. Bone Marrow Transplant 1994;14:995-997.
16. Wang CJK, Schwarz J. The etiology of interstitial pneumonia: identification as Hansenula anomala of a yeast isolated from lungs of infants. Mycopathol Mycol Appl 1958;9:299-306.
17. Murphy N, Damjanovi V, Hart CA, et. al. Infection and colonization of neonates by Hansenula anomala. Lancet 1986:291-293.
18. Nohinek B, Zee-cheng CS, Barnes WG, Dall L, Gibbs HR. Infective endocarditis of a bicuspid aortic valve caused by Hansenula anomala. Am J Med 1987;82:165-168.
19. Marcon MJ, Powell DA. Epidemiology, diagnosis, and management of Malassezia furfur systemic infection. Diagn Microbiol Infect Dis 1987;7:161-175.
20. Teglia O, Schoch PE, Cunha BA. Malassezia furfur infections. Infect Control Hosp Epidemiol 1991;12:676-681.
21. Marcon MJ, Powell DA. Human infections due to Malassezia spp. Clin Microbiol Rev 1992;5:101-119.
22. Barber GR, Brown AE, Kuhn TE, et al. Catheter-related Malassezia furfur fungemia in immunocompromised patients. Am J Med 1993;95:365-370.
23. Sizun J, Karangwa A, Giroux JD, et al. Malassezia furfur-related colonization and infection of central venous catheters. Intensive Care Med 1994;20:496-499.
24. Klotz SA. Malassezia furfur. Infect Dis Clin North Am 1989;3:53-64.
25. Kiehn TE, Gorey E, Brown AE, et al. Sepsis due to Rhodotorula related to use of indwelling central venous catheters. Clin Infect Dis 1992;14:841-846.
26. Rusthoven JJ, Feld RR, Tuffnell PG. Systemic infection by Rhodotorula spp. in the immunocompromised host. J Infect 1984; 8:241-246.
27. Louria DB, Greenberg SM, Molander DW. Fungemia caused by certain nonpathogenic strains of the family cryptococcaceae. Report of two cases due to Rhodotorula and Torulopsis glabrata. N Engl J Med 1960;263:1281-1284.
28. Pore RS, Chen J. Meningitis caused by Rhodotorula. Sabouraudia 1976;14:331-335.
29. Watson KC, Kallichurum S. Brain abscess due to Trichosporon cutaneum. J Med Microbiol 1970;3:191-193.
30. Haupt HM, Merz WG, Beschorner WE, et al. Colonization and infection with Trichosporon species in the immunosuppressed host. J Infect Dis 1983;147:199-203.
31. Martino P, Venditti M, Micozzi A, et al. Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemic patients. Rev Infect Dis 1990;12:570-582.
32. Wong B, Bernard EM, Gold JWM, Armstrong D. Trichosporon infection in three patients with leukemia: evidence for a permissive role for excess iron. In: Program and abstracts of the Twenty-Second Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1982. Abstract 7.
33. Walsh TJ. Trichosporonosis. Infect Dis Clin North Am 1989;3:43-52.
34. Tashiro T, Nagai H, Nagaoka H, et al. Trichosporon beigelii pneumonia in patients with hematologic malignancies. Chest 1995;108:190-195.
35. McManus EJ, Bozdech MJ, Jones JM. Role of latex agglutination test for cryptococcal antigen in diagnosing disseminated infections with Trichosporon beigelii. J Infect Dis 1985;151:1167-1169.
36. Gilbert WR Jr, Fetter BF. Experimental infection in the rabbit with Trichosporon capitatum. J Bacteriol 1962;84:961-966.
37. Venditti M, Posteraro B, Morace G, Martino P. In-vitro comparative activity of fluconazole and other antifungal agents against Blastoschizomyces capitatus. J Chemother 1991;3:13-15.
38. Anaissie E, Gokaslan A, Hachem R, Bodey GP. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review of the literature. Clin Infect Dis 1992;15:781-787.
39. D'Antonio D, Piccolomini R, Fioritoni G, et al. Osteomyelitis and intervertebral discitis caused by Blastoschizomyces capitatus in a patient with acute leukemia. J Clin Microbiol 1994;32:224-227.
40. Jaffe AA. Alimentary toxic aleukia. In: Kadis S, Cicgler A, Ajl SJ, eds. Microbial toxins, vol. VII. New York: Academic, 1971;139.
41. Benajmin RP, Callaway JL, Conant NF, Durham N. Facial granuloma associated with Fusarium infection. Arch Dermatol 1970;101: 598-600.
42. Louie T, Baba F, Shulman M, Jimenez-Lucho V. Endogenous endophthalmitis due to Fusarium: case report and review. Clin Infect Dis 1994;18:585-588.
43. Pflugfelder SC, Flynn HW Jr, Zwinckey TA, et al. Exogenous fungal endophthalmitis. Ophthalmology 1988;95:19-30.
44. Lieberman TW, Ferry AP, Bottone EJ. Fusarium solani endophthalmitis without primary corneal involvement. Am J Opthalmol 1979;88:764-767.
45. Cradon JD, Lerman A, Lutwick LI. Septic arthritis due to Fusarium moniliforme. Rev Infect Dis 1990;12:716-717.
46. Lazarus JA, Schwarz LH. Infection of urinary bladder with an unusual fungus strain, Fusarium. Urol Cutan Rev 1948;52:185-189.
47. Valenstein P, Schell WA. Primary intranasal Fusarium infection. Potential for confusion with rhinocerebral zygomycosis. Arch Pathol Lab Med 1986;110:751-754.
48. Steinberg GK, Britt RH, Enzmann DR, et al. Fusarium brain abscess. J Neurosurg 1983;58:598-608.
49. Rabodonirina M, Piens MA, Monier MF, et al. Fusarium infections in immunocompromised patients: case reports and literature review. Eur J Clin Microbiol Infect Dis 1994;13:152-161.
50. Anaissie E, Kantarjian H, Ro J, et al. The emerging role of Fusarium infections in patients with cancer. Medicine (Baltimore) 1988;67:77-83.
51. Anaissie E, Nelson P, Beremand M, et al. Fusarium-caused by hyalohyphomycosis: an overview. Curr Top Med Mycol 1992;4:231-239.
52. Reuben A, Anaissie E, Nelson PE, et al. Antifungal susceptiblity of 44 clinical isolates of Fusarium species determined by using a broth microdilution method. Antimicrob Agents Chemother 1989;33:1647-1649.
53. Castro LGM, Salebian A, Sotto MN. Hyalohyphomycosis by Paecilomyces Iilacinus in a renal transplant patient and a review of human Paecilomyces species infections. J Med Vet Mycol 1990;28:15-26.
54. Harris LF, Dan BM, Lefkowitz LB Jr, Alford RH. Paecilomyces cellulitis in a renal transplant patient: successful treatment with intravenous miconazole. South Med J 1979;72:897-898.
55. Williamson PR, Kwon-Chung KJ, Gallin JI. Successful treatment of Paecilomyces varioti infection in a patient with chronic granulomatous disease and a review of Paecilomyces species infections. Clin Infect Dis 1992;14:1023-1026.
56. Jade KB, Lyons MF, Gnann JW Jr. Paecilomyces Iilacinus cellulitis in an immunocompromised patient. Arch Dermatol 1986;122:1169-1170.
57. Gordon MA, Norton SW. Corneal transplant infection by Paecilomyces Iilacinus. J Med Vet Mycol 1985;23:295-301.
58. Pettit TH, Olson RJ, Foos RY, Martin WJ. Fungal endophthalmitis following intraocular lens implantation. Arch Ophthalmol 1980;98: 1025-1039.
59. Allevato PA, Ohorodnik JM, Mezger E, Eisses JF. Paecilomyces javanicus endocarditis of native and prosthetic aortic valve. Am J Clin Pathol 1984;82:247-252.
60. Dharmasena FMC, Davies GSR, Catovsky D. Paecilomyces varioti pneumonia complicating hairy cell leukaemia. BMJ 1985;290: 967-968.
61. Dhindsa MK, Naidu J, Singh SM, Jain SK. Chronic suppurativc otitis media caused by Paecilomyces variotii. J Med Vet Mycol 1995;33:59-61.
62. Nankivell BJ, Pacey D, Gordon DL. Peritoneal eosinophilia associated with Paecilomyces variotii infection in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1991;18:603-605.
63. Tan TQ, Ogden AK, Tillman J, et al. Paecilomyces Iilacinus catheter-related fungemia in an immunocompromised pediatric patient. J Clin Microbiol 1992;30: 2479-2483.
64. Deng Z, Ribas JL, Gibson DW, Connor DH. Infections caused by Penicillium mameffei in China and Southeast Asia: review of eighteen published cases and report of four more Chinese cases. Rev Infect Dis 1988;10:640-652.
65. DiSalvo A, Fickling AM, Ajello L. Infection caused by Penicillium marneffei: description of first natural infection in man. Am J Clin Pathol 1973;59:259-263.
66. Supparatpinyo K, Khamwan C, Baosoung V, et al. Disseminated Penicillium marneffei infection in Southeast Asia. Lancet 1994;344: 110-113.
67. Louthrenoo W, Thamprasert K, Sirisanthana T. Osteoarticular penicilliosis marneffei, a report of eight cases and review of the literature. Br J Rheumatol 1994;33:1145-1150.
68. Kok I, Veenstra J, Rietra PJGM, et al. Disseminated Penicillium marneffei infection as an imported disease in HIV-1 infected patients. Neth J Med 1994;44:18-22.
69. Yuen K, Wong SS, Tsang DN, Chau P. Serodiagnosis of Penicillium marneffei infection. Lancet 1994;344:444-446.
70. LoBuglio KF, Taylor JW. Phytogeny and PCR identification of the human pathogenic fungus Penicillium marneffei. J Clin Microbiol 1995;33:85-89.
71. Malloch D, Salkin IF. A new species of scedosporium associated with osteomyelitis in humans. Mycotaxon 1984;21:247-255.
72. Cano J, Guarro J, Mayayo E, Fernandez-Ballart J. Experimental infection with Scedosporium inflatum. J Med Vet Mycol 1992;30:413-420.
73. Wilson CM, O'Rouke EJ, McGinnis MR, Salkin I. Scedosporium inflatum: clinical spectrum of a newly recognized pathogen. J Infect Dis 1990;161:102-107.
74. Wood GM, McCormack JG, Muir DB, et al. Clinical features of human infection with Scedosporium inflatum. Clin Infect Dis 1992;14:1027-1033.
75. Moriarty AP, Crawford GJ, McAllister IL, Constable IJ. Fungal corneoscleritis complicating beta-irradiation-induced scierai necrosis following pterygium excision. Eye 1993;7:525-528.
76. Tapia M, Richard C, Baro J, et al. Scedosporium inflatum infection in immunocompromised haematological patients. Br J Haematol 1994;87:212-214.
77. Madrigal V, Alonso J, Bureo E, et al. Fatal meningoencephalitis caused by Scedosporium inflatum (Scedosporium prolificans) in a child with lymphoblastic leukemia. Eur J Clin Microbiol Infect Dis 1995;14:601-603.
78. Rabodonirina M, Paulus S, Thevenet F, et al. Disseminated Scedosporium prolificans (S. inflatum) infection after single-lung transplantation. Clin Infect Dis 1994;19:138-142.
79. Wise IGV, Speed BR, Ellis DH, Andrews JH. Two fatal infections in immunocompromised patients caused by Scedosporium inflatum. Pathology 1993;25:187-189.
80. Wiest PM, Wiese K, Jacobs MR, et al. Alternaria infection in a patient with acquired immunodeficiency syndrome: case report and review of invasive alternaria infections. Rev Infect Dis 1987;9:799-803.
81. Viviani MA, Tortorano AM, Laria G, et al. Two new cases of cutaneous alternariosis with a review of the literature. Mycopathologia 1986;96:3-12.
82. Iwatsu T. Cutaneous alternariosis. Arch Dermatol 1988;124:1822-1825.
83. Lawson W, Blitzer A. Fungal infections of the nose and paranasal sinuses. Otolaryngol Clin North Am 1993;26:1037-1068.
84. Diaz M, Puente R, Trevino M. Response of long-running Alternaria alternata infection to fluconazole. Lancet 1991;336:513.
85. Morrison VA, Weisdorf DJ. Alternaria: a sinonasal pathogen of immunocompromised hosts. Clin Infect Dis 1993;16:265-270.
86. Jacobson M, Galetta SL, Atlas SW, et al. Bipolaris-inducca orbital cellulitis. J Clin Neuroophthalmol 1992;12:250-256.
87. Antoine GA, Raterink MH. Bipolaris: A serious new fungal pathogen of the paranasal sinus. Otolaryngol Head Neck Surg 1989;100: 158-162.
88. Pingree TF, Holt R, Otto RA, Rinaldi MG. Bipolaris-caused fungal sinusitis. Otolaryngol Head Neck Surg 1992;106:302-305.
89. Straka BK, Cooper PH, Body BA. Cutaneous Bipolaris spicifera infection. Arch Derm 1989;125:1383-1386.
90. Adam RD, Paquin ML, Petersen EA, et al. Phacohyphomycosis caused by the fungal genera Bipolaris and Exserohilum. A report of 9 cases and review of the literature. Medicine (Baltimore) 1986;65:203-217.
91. Yoshimori RN, Moore RA, Itabashi HH, Fujikawa DG. Phaeohyphomycosis of brain. Granulomatous encephalitis caused by Drechslera spicifera. Am J Clin Pathol 1982;77:363-370.
92. McGinnis MR, Campbell G, Gourlcy WK, Lucia HL. Phacohyphomycosis caused by Bipolaris spicifera: an informative case. Eur J Epidemiol 1992;8:383-386.
93. Karim M, Sheikh H, Alam M, Sheikh Y. Disseminated Bipolaris infection in an asthmatic patient: case report. Clin Infect Dis 1993;17:248-253.
94. Yau YCW, de Nanassy J, Summerbell RC, et al. Fungal sternal wound infection due to Curvularia lunata in a neonate with congenital heart disease: case report and review. Clin Infect Dis 1994;19:735-740.
95. Rinaldi MG, Phillips P, Schwartz JG, et al. Human Curvularia infections. Report of five cases and review of the literature. Diagn Microbiol Infect Dis 1987;6:27-39.
96. Loveless MO, Winn RE, Campbell M, Jones SR. Mixed invasive infection with Alternaria species and Curvularia species. Am J Clin Pathol 1981;76:491-493.
97. Grieshop TH, Yarbrough D III, Farrar WD. Case report: phaeohyphomycosis due to Curvularia lunata involving skin and subcutaneous tissue after an explosion at a chemical plant. Am J Med Sci 1993;305:387-389.
98. Berg D, Garcia JA, Schell WA, et al. Cutaneous infections caused by Curvularia pallescens: a case report and review of the spectrum of disease. J Am Acad Dermatol 1995;32:375-378.
99. Subramanyam VR, Rath CC, Mishra M, Chhotrai GP. Subcutaneous infection due to Curvularia species. Mycoses 1993;36:449-450.
100. Guarner J, del Rio C, Williams P, McGowan JE Jr. Case report: fungal peritonitis caused by Cumilaria lunata in a patient undergoing peritoneal dialysis. Am J Med Sci 1989;298:320-323.
101. Robson AM, Graver RD. Curvularia urinary tract infection: a case report. Pediatr Nephrol 1994;8:83-84.
102. Kaufman SM. Curvularia endocarditis following cardiac surgery. Am J Clin Pathol 1971;56:466-470.
103. Bryan CS, Smith CW, Berg DE, Karp RB. Curvularia lunata endocarditis treated with terbinafine: case report. Clin Infect Dis 1993;16:30-32.
104. Brubaker LH, Steele JC Jr, Rissing JP. Cure of Curvularia pneumonia by amphotericin B in a patient with megakaryocytic leukemia. Arch Pathol Lab Med 1988;112:1178.
105. Friedman AD, Campos JM, Rorke LB, et al. Fatal recurrent Curvularia brain abscess. J Pediatr 1981;99:413-415.
106. Pierce NF, Millan JC, Bender BS, Curtis JL. Disseminated Curvularia infection. Arch Pathol Lab Med 1986;110:959-961.
107. Rohwedder JJ, Simmons JL, Colfer H, Gatmaitan B. Disseminated Curvularia lunata infection in a football player. Arch Intern Med 1979;139:940-941.
108. Sharkey PK, Graybill JR, Rinaldi MG, et al. Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol 1990;23:577-586.
109. Aquino VM, Nonell JM, Krisher K, Mustafa MM. Fatal disseminated infection due to Exserohilum rostratum in a patient with aplastic anemia: case report and review. Clin Infect Dis 1995;20:176-178.
110. Aviv JE, Lawson W, Bottone EJ, et al. Multiple intracranial mucoceles associated with phaeohyphomycosis of the paranasal sinuses. Arch Otolaryngol Head Neck Surg 1990;116: 1210-1213.
111. Hsu MML, Lee HYY. Cutaneous and subcutaneous phaeohyphomycosis caused by Exserohilum rostratum. J Am Acad Dermatol 1993;28:340-344.
112. Burgess GE, Walls CT, Maize JC. Subcutaneous phaeohyphomycosis caused by Exserohilum rostratum in an immunocompent host. Arch Dermatol 1987;123: 1346-1350.
113. Douer D, Goldschmied-Reouven A, Segev G, Ben-Bassat I. Human Exserohilum and Bipolaris infections: report of Exserohilum nasal infection in a neutropenic patient with acute leukemia and review of the literature. J Med Vet Mycol 1987;25:235-241.
114. Ziefer A, Connor DH. Phaeomycotic cyst: a clinicopathologic study of twenty-five patients. Am J Trop Med Hyg 1980;29:901-911.
115. Gueho E, Bonnefoy A, Luboinski J, et al. Subcutaneous granuloma caused by Phialophora richardsiae: case report and review of the literature. Mycoses 1989;32:219-223.
116. Fincher RME, Fisher JF, Padhye AA, et al. Subcutaneous phaeohyphomycotic abscess caused by Phialophora parasilica in a renal allograph recipient. J Med Vet Mycol 1988;26:311-314.
117. Pitrak DL, Koneman EW, Estupinan RC, Jackson J. Phialophora richardsiae infection in humans. Rev Infect Dis 1988;10:1195-1203.
118. Wong PK, Ching UTW, Kwon-Chung KJ, Meyer RD. Disseminated Phialophora parasitica infection in humans: case report and review. Rev Infect Dis 1989;11:770-775.
119. Ferraro FA, Morgan MA. A case of disseminated Phialophora parasitica infection. Arch Pathol Lab Med 1989;113:1379-1381.
120. Hironaga M, Nakano K, Yokoyama I, Kitajima J. Phialophora repens, an emerging agent of subcutaneous phaeohyphomycosis in humans. J Clin Microbiol 1989;27:394-399.
121. Duggan JM, Kauffman CA. Phialophora verrucosa infection in an AIDS patient. Mycoses 1995;38:215-218.
122. Rinaldi MB, McCoy EL, Winn DF. Gluteal abscess caused by Phialophora hoffmannii and review of the role of this organism in human mycoses. J Clin Microbiol 1982;16: 181-185.
123. Matsumoto T, Matsuda T, McGinnis MR, Ajello L. Clinical and mycological spectra of Wangiella dermatitidis infections. Mycoses 1993;36:145-155.
124. Hohl PE, Holley P Jr, Prevost E, et al. Infections due to Wangiella dermatitidis in humans: report of the first documented case from the United States and a review of the literature. Rev Infect Dis 1983;5:854-864.
125. Polak A. Experimental infection of mice by Fomecaea pedrosoi and Wangiella dermatitidis. J Med Vet Mycol 1984;22:167-169.
126. Tsai CY, Lu YC, Wang LT, et al. Systemic chronioblastoniycosis due to Hormodendrum dermatitidis (Kano) Conant. Report of the first case in Taiwan. Am J Clin Pathol 1966; 46:103-114.
127. Vartian CV, Shlaes DM, Padhye AA, Ajello L. Wangiella dermatitidis endocarditis in an intravenous drug user. Am J Med 1985;78: 703-707.
128. Margo CE, Fitzgerald CR. Postoperative endophthalmitis caused by Wangiella dermatitidis. Am J Ophthalmol 1990;110: 322-323.
129. Dixon DM, Merz WG, Elliott HL, Macleay S. Experimental central nervous system phaeohyphomycosis following intranasal inoculation of Xylohypha bantiana in cortisonetreated mice. Mycopathologia 1987;100: 145-153.
130. Heney C, Song E, Kellen A, et al. Cerebral phaeohyphomycosis caused by Xylohypha bantiana. Eur J Clin Microbiol Infect Dis 1989;8:984-988.
131. Dixon DM, Walsh TJ, Merz WG, McGinnis MR. Infections due to Xylohypha bantiana (Cladosporium trichoides). Rev Infect Dis 1989;11:515-525.
132. Palaoglu S, Sav A, Basak T, et al. Cerebral phacohyphomycosis. Neurosurgery 1993;33: 894-897.
133. Bennett JE, Bonner H, Jennings AE, Lopez RI. Chronic meningitis caused by Cladosporium trichoides. Am J Clin Pathol 1973; 59:398-407.
134. Turker A, Altinors N, Aciduman A, et al. MRI findings and encouraging fluconazole treatment results of intracranial Cladosporium trichoides infection. Infection 1995;23:60-62.